Press Release

Generates First Quarter Net Revenue Growth of 65% Year-Over-Year Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the first quarter ended March 31, 2026. First Quarter Financial Highlights Recent Business Highlights “We are very pleased with our first quarter performance, which reflects accelerating revenue growth and intensifying commercial momentum across […]

Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights Full Year and Recent Business Highlights “2025 was a transformational year for Shoulder Innovations. We continued to add new surgeon customers at an accelerated pace, drove rapid commercial adoption of

Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio Grand Rapids, MI – September 22, 2025 – Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem (“InSet™ 70”). The

GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights “We are pleased with both our second quarter performance, which was in-line